Redx Pharma

Pharmaceutical Manufacturing • Macclesfield, England, United Kingdom • 21-50 Employees

Company overview

Headquarters	Block 33, Mereside, Alderley Park, Macclesfield SK10 4TG, GB
Phone number	+441625469900
Website	redxpharma.com
NAICS	3254
SIC	283
Keywords	Biotech, Pharmaceuticals, Oncology, Drug Discovery And Development, Fibrosis
Founded	2010
Employees	21-50
Socials

Key Contact at Redx Pharma

Lisa Anson

Chief Executive Officer

Redx Pharma Email Formats

Redx Pharma uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@redxpharma.com), used 79.5% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@redxpharma.com	79.5%
{first name}.{last name}	john.doe@redxpharma.com	20.5%

About Redx Pharma

Redx Pharma is a clinical-stage biotechnology company focused on the discovery and development of novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic diseases Our team of scientists are based at our labs at Alderley Park, Cheshire, the UK’s largest single site life science campus. The team is made up of world class medicinal chemistry, biology and clinical capability with deep-rooted biotech and large pharma experience. Redx's lead asset, the selective ROCK2 inhibitor, zelasudil (RXC007), is in development for idiopathic pulmonary fibrosis and commenced a Phase 2 clinical trial in Q4 2022. Redx’s second ROCK inhibitor candidate, RXC008, a GI-targeted pan-ROCK inhibitor for the treatment of fibrostenotic Crohn’s disease, commenced a Phase 1 clinical trial in Q1 2024. The Company's lead oncology product candidate, the Porcupine inhibitor, zamaporvint (RXC004), commenced a Phase 2 programme in November 2021. The Company has a strong track record of discovering new drug candidates through its core strengths in medicinal chemistry and translational science, enabling the Company to discover and develop differentiated therapeutics against biologically or clinically validated targets. Read more about our company at https://www.redxpharma.com/about-us/ If you're interested in joining us, please visit https://www.redxpharma.com to see what job vacancies we currently have.

Redx Pharma revenue & valuation

Annual revenue	$13,600,000
Revenue per employee	$282,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$43,300,000
Total funding	$43,600,000

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

C-Suite

Head

Employees by Department

Redx Pharma has 18 employees across 10 departments.

Departments

Number of employees

Funding Data

Explore Redx Pharma's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-06-19	14	$43,600,000

Funding Insights

$43,600,000

Total funding amount

$43,600,000

Most recent funding amount

Number of funding rounds

Redx Pharma Tech Stack

Discover the technologies and tools that power Redx Pharma's digital infrastructure, from frameworks to analytics platforms.

Gravity Forms

Form builders

jQuery UI

JavaScript libraries

Google Maps

Maps

Microsoft 365

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

Akismet

WordPress plugins

WordPress

Blogs

Google Analytics

Analytics

Popup Maker

WordPress plugins

Yoast SEO

SEO

Frequently asked questions

Redx Pharma is located in Macclesfield, England, GB.

You can reach Redx Pharma at +441625469900.

Redx Pharma was founded in 2010, making it 16 years old. The company has established itself as a significant player in its industry over this time.

Redx Pharma has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Redx Pharma has raised a total of $43,600,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Redx Pharma

Lisa Anson

Chief Executive Officer

4.8

40,000 users